A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. El-Sadoni M, Shboul SA, Alhesa A, Shahin NA, et al. Cancer Chemother Pharmacol 2023 Mar 24. doi: 10.1007/s00280-023-04523.

Read + Share

Amedeo Smart

Independent Medical Education

El-Sadoni M, Shboul SA, Alhesa A, Shahin NA, et al. A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. Cancer Chemother Pharmacol 2023 Mar 24. doi: 10.1007/s00280-023-04523.
PMID: 36964435